Status | Study |
Completed |
Study Name: A Long-Term Extension Study of RP103-MITO-001 (NCT02023866) to Assess RP103 in Children With Inherited Mitochondrial Disease Condition: Mitochondrial Diseases Date: 2015-06-10 Interventions: Drug: Cysteamine Bitartrate Delayed-release Capsules Treatment with experimental drug as detailed in arm |
Recruiting |
Study Name: Inherited Retinal Degenerative Disease Registry Condition: Eye Diseases Hereditary Retinal Disease Achromatopsia Date: 2015-04-03 |
Completed |
Study Name: Effect Of The System In The Enriched Fat Metabolism Of The Child Reached Mitochondrial Cytopathy Condition: Mitochondrial Cytopathies Disorders Date: 2015-03-02 Interventions: Other: high fat diet high fat |
Completed |
Study Name: Nutritional Assessment in Mitochondrial Cytopathy Condition: Mitochondrial Diseases Mitochondrial Myopathies Date: 2015-02-24 |
Completed |
Study Name: Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease Condition: Inherited Mitochondrial Disease, Including Leigh Syndrome Date: 2013-12-17 Interventions: Drug: Cysteamine Bitartrate Cysteamine Bitartrate Delayed-release Capsules |
Recruiting |
Study Name: North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) Condition: Mitochondrial Disorders Mitochondrial Genetic Disorders Mi Date: 2012-09-25 |